The temporal relationship between primary genital human papillomavirus (HPV) infections and the induction of antibodies against viral antigens has not been established. In order to address this question we studied a cohort of 110 women and 48 men with multiple heterosexual partners, who were followed for 220 person-years during which they made 583 visits to the sexually transmitted diseases clinic of the Amsterdam Public Health Service. At each visit spatula or brush samples from multiple anogenital and oral sites were collected for HPV DNA analysis by PCR. Serum samples were also collected and analysed for serological reactivity to peptides derived from the L1, L2 and E2 regions of HPV types 6, 16 and 18 as well as to bovine papillomavirus and HPV-16 virus-like particles. Seroconversions for at least three antigens were found among 16/158 patients. Of these, 10/16 were HPV-positive and in 5/16 cases seroconversions occurred concomitantly with the detection of HPV DNA. Analysis of participants who were HPV-negative at entry, but became HPV DNA-positive during follow-up revealed that antibodies against several HPV antigens were regularly induced at the time of a new HPV infection, in particular the IgG responses against HPV-16 virus-like particles and against the HPV-16 E2-derived peptide 245. Whereas the responses induced among the women with new HPV-16 infection tended to continuously increase, the responses among the men with any type of new HPV infection were mostly transient and disappeared during follow-up. In conclusion, we find that antibody responses to multiple viral antigens are often induced following the detection of genital HPV infection, that the type-specificity of the response is limited and that transient responses are common.
DillnerJ.1990; Mapping of linear epitopes of human papillomavirus type 16: the E1, E2, E4, E5, E6 and E7 open reading frames. International Journal of Cancer 46:703–711
DillnerJ.,
DillnerL.,
RobbJ.,
WillemsJ.,
JonesI.,
LancasterW.,
SmithR.,
LernerR.1989; A synthetic peptide defines a serologic IgA response to a human papillomavirus-encoded nuclear antigen expressed in virus-carrying cervical neoplasia. Proceedings of the National Academy of Sciences. USA 86:3838–3841
DillnerJ.,
DillnerL.,
UtterG.,
EklundC.,
RotalaA.,
CostaS.,
DiLucaD.1990; Mapping of linear epitopes of human papillomavirus type 16: the L1 and L2 open reading frames. International Journal of Cancer 45:529–535
DillnerJ.,
LennerP.,
LehtinenM.,
EklundC.,
HeinoP.,
WiklundF.,
HallmansG.,
StendahlU.1994; A population-based seroepidemiological study of cervical cancer. Cancer Research 54:134–141
DillnerL.,
HeinoP.,
Moreno-LopezJ.,
DillnerJ.1991; Antigenic and immunogenic epitopes shared by human papillomavirus type 16 and bovine, canine and avian papillomaviruses. Journal of Virology 65:6862–6871
HooykaasC.,
van der PligtJ.,
van DoornumG. J. J.,
van der LindenM. M. D.,
CoutinhoR. A.1989; Heterosexuals at risk for HIV: differences between private and commercial partners in sexual behaviour and condom use. AIDS 3:525–532
JenisonS. A.,
Xiu-pingY.,
ValentineJ. M.,
KoutskyL. A.,
ChristiansenA. E.,
BeckmannA. M.,
GallowayD. A.1990; Evidence of prevalent genital-type human papillomavirus infections in adults and children. Journal of Infectious Diseases 162:60–69
KirnbauerR.,
TaubJ.,
GreenstoneH.1993; Efficient self assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles. Journal of Virology 67:6929–6936
KirnbauerR.,
HubbertN. L.,
WheelerC. M.,
BeckerT. M.,
LowyD. R.,
SchillerJ. T.1994; A virus-like particle ELISA detects serum antibodies in a majority of women infected with human papillomavirus type 16. Journal of the National Cancer Institute 86:494–499
KrchňákV.,
VágnerJ.,
SuchánkovaA.,
KrčmářM.,
RitterováL.,
VonkaV.1990; Synthetic peptides derived from E7 region of human papillomavirus type 16 used as antigens in ELISA. Journal of General Virology 11:2719–2724
LehtinenM.,
ParkkonenP.,
LuotoH.,
Yla-OutinenA.,
RomppanenU.,
RantalaI.,
PaavonenJ.1990; Antipeptide IgA antibodies to a human papillomavirus type 16 E2 derived synthetic peptide predict the natural history of cervical HPV infections. Serono Symposia 78:509–519
LehtinenM.,
LeminenA.,
PaavonenJ.,
LehtovirtaP.,
HyötyH.,
VestrinenE.,
DillnerJ.1992; Predominance of serum antibodies to synthetic peptide stemming from HPV 18 open reading frame E2 in cervical adenocarcinoma. Journal of Clinical Pathology 45:494–497
LehtinenM.,
NiemeläJ.,
DillnerJ.,
ParkkonenP.,
NummiT.,
LiskiE.,
NieminenP.,
ReunalaT.,
PaavonenJ.1993; Evaluation of serum antibody response to a newly identified B-cell epitope in the minor nucleocapsid protein L2 of human papillomavirus type 16. Clinical and Diagnostic Virology 1:153–165
MannV. M.,
Loo de LaoS.,
BrenesM.,
BrintonL. A.,
RawisJ. A.,
GreenM.,
ReevesW. C.,
RawisW. E.1990; Occurrence of IgA and IgG antibodies to select peptides representing human papillomavirus type 16 among cervical cancer cases and controls. Cancer Research 50:7815–7819
RosenfeldW. D.,
RoseE.,
VermundS. H.,
SchreiberK.,
BurkR. D.1992; Follow-up evaluation of cervicovaginal human papillomavirus infection in adolescents. Journal of Pediatrics 121:307–311
SchiffmanM. H.,
BauerH. M.,
HooverR. N.,
GlassA. G.,
CadellD. M.,
RushB. B.,
ScottP. R.,
ShermanM. E.,
KurmanR. J.,
WacholderS.,
StantonC. K.,
ManosM. M.1992; Epidemiological evidence that human papillomavirus infection causes most cervical intraepithelial neoplasia. Journal of the National Cancer Institute 85:958–963
SyrjänenK.,
SyrjanenS.1990; Epidemiology of human papilloma virus infections and genital neoplasia. Scandinavian Journal of Infectious Diseases Supplement 697–17
van der LindenM. M. D.,
van der VeldeF. W.,
HooykaasC.,
van DoornumG. J. J.,
CoutinhoR. A.1990; HIV-prevalentie onder heterosexuelen met veel wisselende partners in Amsterdam. Nederlands Tijdschrift voor Geneeskunde 134:1361–1364
van DoornumG. J. J.,
HooykaasC.,
JuffermansL. H. J.,
Van der LansS. M. G. A.,
van der LindenM. M. D.,
CoutinhoR. A.,
QuintW. G. V.1992; Prevalence of human papillomavirus infections among heterosexual men and women with multiple sexual partners. Journal of Medical Virology 37:13–21
van DoornumG. J. J.,
PrinsM.,
PronkL.,
CoutinhoR. A.,
DillnerJ.1994; Antibody responses to defined epitopes of human papillomavirus type 16 in relation to genital and anorectal presence of HPV DNA, a prospective study. Clinical and Diagnostic Laboratory Immunology 1:633–639
WikströmA.,
LidbrinkP.,
EklundC.,
von KroghG.,
DillnerJ.1992; Levels of IgG antibodies against defined epitopes of the L1 and L2 capsid proteins of human papillomavirus type 6 are elevated in men with a history of condylomata acuminata. Journal of Clinical Microbiology 30:1795–1800
YaegashiN.,
JenisonS. A.,
BatraM.,
GallowayD. A.1992; Human antibodies recognize multiple distinct type-specific and cross-reactive regions of the minor capsid proteins of human papillomavirus types 6 and 11. Journal of Virology662008–2019